029HO14062 GILLESPY

Print/PDF
Registration Name DE-SU GILLESPY-ET
Registration Number HOUSA000063449626
Primary NAAB Code 029HO14062
Secondary Code(s) 629HO14026, 529HO14062, 530HO14062, 531HO14062, 532HO14062, 533HO14062
Status Inactive
Controller Name ABS Global (29)
Date of Birth 6/29/2007
aAa 312
DMS 234,123
GFI 9.1%
Genetic Codes * BY TV TL TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire SANDY-VALLEY BOLTON-ET
MGS PICSTON SHOTTLE-ET
Beta Casein A1A2
Kappa Casein AA
Beta Lactoglobulin AA
INDEXES
NM$ -179, 93% R CM$ -214
NM Percentile 15% FM$ -93
GTPI 2309 GM$ -245
PRODUCTION TRAITS
31044 Dtrs 7434 herds 17 % US 99% R
Milk 1141 Fat, % -12 , -0.22%
SCS 2.86, 99% R Protein, % 7 , -0.11%
Feed Saved -114 , 63% R Milking Speed 6.24 , 80% R
Health & Fertility
Productive Life -2.0      99% R Mastitis -0.7      96% R
Heifer Livability 1.1       88% R Metritis -2.8      90% R
Livability -0.9      96% R D. Abom 0.4      96% R
DPR -3.7      99% R Ketosis -1.3      91% R
HCR -0.7      97% R R. Placenta -0.3      92% R
CCR -4.4      99% R Milk Fever 0.0      80% R
SCR -        -
Calving Traits
Sire CE 2.1      99% R 35939 Obs
Daughter CE 2.4      98% R 6188 Obs, 16666 Dtrs
Sire SB 4.0      98% R 36569 Obs
Daughter SB 5.5      98% R 5650 Obs, Dtrs
Gestation Length 2.3      99% R 1059 Obs, 10893 Dtrs
Early First Calving -1.1      98% R 1081 Obs, 4916 Dtrs

CDCB August 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2025
16510 Dtrs 4576 herds 98% R
PTA Type 0.57 UDC 0.11
FLC 0.73 BWC -0.22
Linear Traits
Stature 0.68
Tall
Strength 0.07
Strong
Body Depth 0.78
Deep
Dairy Form 1.46
Open
Rump Angle 1.76
Sloped
Thurl Width 1.16
Wide
Rear Legs-Side View 1.09
Curved
Rear Legs-Rear View 0.62
Straight
Foot Angle 0.70
Steep
Feet & Legs Score 0.92
High
F.U. Attachment -0.46
Weak
Rear Udder Height 0.59
High
Rear Udder Width 0.31
Wide
Udder Cleft 1.06
Strong
Udder Depth -0.29
Deep
Front Teat Placement 1.32
Close
Rear Teat Placement 1.74
Close
Teat Length 0.29
Long
-2
0
2

CDCB August 2025; Base of Evaluation: HO